N- and S-donor leaving groups in triazole-based ruthena(ii)cycles: potent anticancer activity, selective activation, and mode of action studies-Reference-Cited by-同舟云学术

N- and S-donor leaving groups in triazole-based ruthena(ii)cycles: potent anticancer activity, selective activation, and mode of action studies

Published:2018 Issue:13 Volume:47 Page:4625-4638
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Riedl Christoph A.¹²³⁴⁵,Hejl Michaela¹²³⁴⁵,Klose Matthias H. M.¹²³⁴⁵^ORCID,Roller Alexander¹²³⁴⁵,Jakupec Michael A.¹²³⁴⁵^ORCID,Kandioller Wolfgang¹²³⁴⁵^ORCID,Keppler Bernhard K.¹²³⁴⁵

Affiliation:

1. Institute of Inorganic Chemistry

2. Faculty of Chemistry

3. University of Vienna

4. 1090 Vienna

5. Austria

Abstract

The functionalization of cycloruthenated triazole arene complexes with N- or S-donors affords pH or redox-activatable complexes with high cytotoxic activities.

Funder

Universität Wien

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2018/DT/C8DT00449H

Reference45 articles.

1. From bench to bedside – preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)

2. Axillary lymph node coverage of tangent radiotherapy: Comparison of supine versus prone positioning.

3. M. A. Jakupec , W.Kandioller , B.Schoenhacker-Alte , R.Trondl , W.Berger and B. K.Keppler , in Ruthenium Complexes – Photochemical and Biomedical Applications , ed. A. Holder , J. L. Bullock , W. R. Browne , M. A. Lawrence and L. Lilge , Wiley-VCH, Weinheim , 2018 , pp. 271–291

4. The fragment bis(acetylacetonato)ruthenium: a meeting-point of coordination and organometallic chemistry

5. In Vitro and in Vivo Evaluation of Ruthenium(II)−Arene PTA Complexes

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DLPNO-CCSD(T) and DFT study of the acetate-assisted C–H activation of benzaldimine at [RuCl₂(p-cymene)]₂: the relevance of ligand exchange processes at ruthenium(ii) complexes in polar protic media;Dalton Transactions;2024

2. Investigating the anticancer potential of 4-phenylthiazole derived Ru(ii) and Os(ii) metalacycles;Dalton Transactions;2024

3. Construction of homo and heteronuclear Ru(II), Ir(III) and Re(I) complexes for target specific cancer therapy;Coordination Chemistry Reviews;2022-06

4. The straightforward synthesis of N-coordinated ruthenium 4-aryl-1,2,3-triazolato complexes by [3 + 2] cycloaddition reactions of a ruthenium azido complex with terminal phenylacetylenes and non-covalent aromatic interactions in structures;RSC Advances;2022

5. Design concepts of half-sandwich organoruthenium anticancer agents based on bidentate bioactive ligands;Coordination Chemistry Reviews;2021-10